Tag Archives: Lead
04
Jul
Lead Investigator Reviews Early Safety Signals from Novel VMS Agents
During the trial, the treatment was generally well tolerated, with only a small proportion of seriou...
04
Jul
Lead Investigator Perspectives on the Future of VMS Management
The findings from the OASIS 4 trial, along with those from OASIS 1, 2, and 3 in women without breast...
20
Jun
Lead Investigator Reviews Trial Design
At the ASCO 2025 meeting, the primary results of a major phase 3 randomized, placebo-controlled tria...
13
Jun
Lead Investigator Insights on Adjuvant Endocrine Therapy Landscape
Hormone receptor–positive, HER2-negative breast cancer is the most common subtype, accounting for ab...